Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 Peter Tang + 619 word(s) 619 2020-12-30 02:34:35

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Tang, P. Neurofibromatosis Type 1. Encyclopedia. Available online: https://encyclopedia.pub/entry/5974 (accessed on 20 September 2026).
Tang P. Neurofibromatosis Type 1. Encyclopedia. Available at: https://encyclopedia.pub/entry/5974. Accessed September 20, 2026.
Tang, Peter. "Neurofibromatosis Type 1" Encyclopedia, https://encyclopedia.pub/entry/5974 (accessed September 20, 2026).
Tang, P. (2021, January 04). Neurofibromatosis Type 1. In Encyclopedia. https://encyclopedia.pub/entry/5974
Tang, Peter. "Neurofibromatosis Type 1." Encyclopedia. Web. 04 January, 2021.
Neurofibromatosis Type 1
Edit
This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/condition/neurofibromatosis-type-1

Neurofibromatosis type 1 is a condition characterized by changes in skin coloring (pigmentation) and the growth of tumors along nerves in the skin, brain, and other parts of the body. The signs and symptoms of this condition vary widely among affected people.

genetic conditions

References

  1. Arun D, Gutmann DH. Recent advances in neurofibromatosis type 1. Curr OpinNeurol. 2004 Apr;17(2):101-5. Review. Citation on PubMed
  2. Baralle D, Mattocks C, Kalidas K, Elmslie F, Whittaker J, Lees M, Ragge N,Patton MA, Winter RM, ffrench-Constant C. Different mutations in the NF1 gene areassociated with Neurofibromatosis-Noonan syndrome (NFNS). Am J Med Genet A. 2003 May 15;119A(1):1-8. Citation on PubMed
  3. De Luca A, Bottillo I, Sarkozy A, Carta C, Neri C, Bellacchio E, Schirinzi A, Conti E, Zampino G, Battaglia A, Majore S, Rinaldi MM, Carella M, Marino B,Pizzuti A, Digilio MC, Tartaglia M, Dallapiccola B. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. Am J Hum Genet. 2005 Dec;77(6):1092-101. Epub 2005 Oct 26. Citation on PubMed or Free article on PubMed Central
  4. Friedman JM. Neurofibromatosis 1. 1998 Oct 2 [updated 2019 Jun 6]. In: AdamMP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle;1993-2020. Available from http://www.ncbi.nlm.nih.gov/books/NBK1109/ Citation on PubMed
  5. Hart L. Primary care for patients with neurofibromatosis 1. Nurse Pract. 2005 Jun;30(6):38-43. Review. Erratum in: Nurse Pract. 2005 Jul;30(7):4. Citation on PubMed
  6. Hüffmeier U, Zenker M, Hoyer J, Fahsold R, Rauch A. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene. Am J Med Genet A. 2006 Dec 15;140(24):2749-56. Citation on PubMed
  7. Kandt RS. Tuberous sclerosis complex and neurofibromatosis type 1: the twomost common neurocutaneous diseases. Neurol Clin. 2003 Nov;21(4):983-1004.Review. Citation on PubMed
  8. Levine TM, Materek A, Abel J, O'Donnell M, Cutting LE. Cognitive profile ofneurofibromatosis type 1. Semin Pediatr Neurol. 2006 Mar;13(1):8-20. Review. Citation on PubMed
  9. Reynolds RM, Browning GG, Nawroz I, Campbell IW. Von Recklinghausen'sneurofibromatosis: neurofibromatosis type 1. Lancet. 2003 May 3;361(9368):1552-4.Review. Citation on PubMed
  10. Rose VM. Neurocutaneous syndromes. Mo Med. 2004 Mar-Apr;101(2):112-6. Review. Citation on PubMed
  11. Theos A, Korf BR; American College of Physicians; American PhysiologicalSociety. Pathophysiology of neurofibromatosis type 1. Ann Intern Med. 2006 Jun6;144(11):842-9. Review. Citation on PubMed
  12. Tonsgard JH. Clinical manifestations and management of neurofibromatosis type 1. Semin Pediatr Neurol. 2006 Mar;13(1):2-7. Review. Citation on PubMed
  13. Ward BA, Gutmann DH. Neurofibromatosis 1: from lab bench to clinic. PediatrNeurol. 2005 Apr;32(4):221-8. Review. Citation on PubMed
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Genetics & Heredity
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Peter Tang
View Times: 904
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 20 Jan 2021
Table of Contents
    Notice
    You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
    OK
    Confirm
    Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
    Yes
    No
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    There is no comment~
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    ${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
    Submit
    Cancel
    Confirm
    Are you sure to Delete?
    Yes No
    Academic Video Service
    Feedback